Curis Shareholders Equity:
30.25M for March 31, 2013Curis Historical Shareholders Equity Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| March 31, 2013 | 30.25M |
| Dec. 31, 2012 | 34.27M |
| Sept. 30, 2012 | 45.72M |
| June 30, 2012 | 47.05M |
| March 31, 2012 | 47.60M |
| Dec. 31, 2011 | 39.88M |
| Sept. 30, 2011 | 32.41M |
| June 30, 2011 | 36.13M |
| March 31, 2011 | 40.51M |
| Dec. 31, 2010 | 45.52M |
| Sept. 30, 2010 | 50.64M |
| June 30, 2010 | 51.81M |
| March 31, 2010 | 53.56M |
| Dec. 31, 2009 | 33.05M |
| Sept. 30, 2009 | 34.43M |
| June 30, 2009 | 35.24M |
| March 31, 2009 | 38.91M |
| Dec. 31, 2008 | 37.22M |
| Sept. 30, 2008 | 38.77M |
| June 30, 2008 | 42.82M |
| March 31, 2008 | Go Pro |
| Dec. 31, 2007 | Go Pro |
| Sept. 30, 2007 | Go Pro |
| June 30, 2007 | Go Pro |
| March 31, 2007 | Go Pro |
| Dec. 31, 2006 | Go Pro |
| Sept. 30, 2006 | Go Pro |
| June 30, 2006 | Go Pro |
| March 31, 2006 | Go Pro |
| Dec. 31, 2005 | Go Pro |
| Sept. 30, 2005 | Go Pro |
| June 30, 2005 | Go Pro |
| March 31, 2005 | Go Pro |
| Dec. 31, 2004 | Go Pro |
| Sept. 30, 2004 | Go Pro |
| June 30, 2004 | Go Pro |
| March 31, 2004 | Go Pro |
| Dec. 31, 2003 | Go Pro |
| Sept. 30, 2003 | Go Pro |
| June 30, 2003 | Go Pro |
| March 31, 2003 | Go Pro |
| Dec. 31, 2002 | Go Pro |
| Sept. 30, 2002 | Go Pro |
| June 30, 2002 | Go Pro |
| March 31, 2002 | Go Pro |
| Dec. 31, 2001 | Go Pro |
| Sept. 30, 2001 | Go Pro |
| June 30, 2001 | Go Pro |
| March 31, 2001 | Go Pro |
| Dec. 31, 2000 | Go Pro |
About Shareholders' Equity
Shareholders' equity is difference between a company's total assets and total liabilities. Also referred to as stockholders' equity, net worth, or net assets.
Learn More
CRIS Shareholders Equity Benchmarks
| Companies | |
|---|---|
| Roche | 18.33B |
| Cerus Corporation | 60.79M |
| Sunesis Pharmaceuticals | 1.104M |
CRIS Shareholders Equity Rankings
| Overall |
62nd percentile 6350 of 16782 |
| Sector |
65th percentile 482 of 1410 in Healthcare |
| Industry |
70th percentile 135 of 454 in Biotechnology |
CRIS Shareholders Equity Range, Past 5 Years
| Minimum | 30.25M | Mar 2013 |
| Maximum | 53.56M | Mar 2010 |
| Average | 40.79M |
